Thiago Bueno de Oliveira

ORCID: 0000-0002-6472-3596
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Head and Neck Surgical Oncology
  • Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Cancer Cells and Metastasis
  • Prostate Cancer Treatment and Research
  • Drug-Induced Adverse Reactions
  • Sarcoma Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Oral health in cancer treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Oral and Maxillofacial Pathology
  • Chemotherapy-related skin toxicity
  • Advanced Breast Cancer Therapies
  • Cancer, Stress, Anesthesia, and Immune Response
  • Radiomics and Machine Learning in Medical Imaging
  • Neuroblastoma Research and Treatments
  • Lung Cancer Diagnosis and Treatment
  • Cancer Treatment and Pharmacology
  • Radiopharmaceutical Chemistry and Applications
  • Metastasis and carcinoma case studies
  • Chronic Lymphocytic Leukemia Research
  • Neurofibromatosis and Schwannoma Cases

AC Camargo Hospital
2015-2024

Sociedade Brasileira de Oncologia Clínica
2021

Society of Surgical Oncology
2015

Técnicas Reunidas (Spain)
2015

Circulating tumor cells (CTCs) have been reported to be a relevant prognostic biomarker in metastatic patients. However, their clinical use and impact is still under debate. We thus comparatively kinetically assessed two CTC detection methods according the patient's follow up.CTC counting characterization were repeatedly performed during up patient with undifferentiated non-small cell lung cancer by using cytokeratin (CK)-dependent immunomagnetic separation (Miltenyi) CK-independent,...

10.3978/j.issn.2072-1439.2013.09.18 article EN PubMed 2013-10-01

Colonialism's enduring impact on Brazil has had significant implications for health and oncology outcomes. This historical essay delves into the profound changes brought about by transatlantic slave trade from Africa to Americas, particularly in terms of its influence economy, sociocultural habits, explores connections between colonial period's operational dynamics current epidemiological panorama head neck cancer (HNC). The examination provides original insights role tobacco alcohol...

10.1016/j.lana.2024.100690 article EN cc-by The Lancet Regional Health - Americas 2024-02-09

To assess the prevalence of cutaneous and oral immune-related adverse events (irAEs) in cancer patients, risk factors for its development, overall survival (OS).

10.1111/odi.15056 article EN Oral Diseases 2024-06-27

Abstract Background Circulating tumor microemboli (CTM) are clusters of circulating cells (CTCs), involved in metastasis, as also transforming growth factor‐β (TGF‐β). The purpose this study was to verify their role progression‐free survival (PFS). Methods Blood from patients with locally advanced head and neck squamous cell carcinoma (HNSCC; n = 53) analyzed 2 moments. TGF‐β receptor I (TGF‐βRI) expression evaluated by immunocytochemistry. Results Comparing CTM1 (baseline) CTM2 (first...

10.1002/hed.24899 article EN Head & Neck 2017-08-17

Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such most Latin America. International guidelines cannot always be applied to population from large region specific conditions. This study established American guideline for care of patients head cancer presented evidence HNSCC management considering availability oncologic benefit. A panel composed 41 experts systematically...

10.1200/go.23.00343 article EN cc-by-nc-nd JCO Global Oncology 2024-04-01

Background : Liver metastases of colorectal cancer are frequent and potentially fatal event in the evolution patients with these tumors. Aim In this module, was contextualized clinical situations parameterized epidemiological data results various treatment modalities established. Method: Was realized deep discussion on detecting staging metastatic cancer, as well employment imaging methods evaluation response to instituted systemic therapy. Results The next step based definition which would...

10.1590/s0102-6720201500040002 article EN ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2015-12-01

Objective The objective of this study was to assess the clinical value 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) after first cycle induction chemotherapy (IC) in locally advanced squamous cell carcinoma head and neck (LASCCHN). Methods findings A prospective, single-arm, single center performed, with patients enrolled between February 2010 July 2013.Patients (n = 49) stage III/IVA–B LASCCHN who underwent IC taxanes, cisplatin, fluorouracil were...

10.1371/journal.pone.0200823 article EN cc-by PLoS ONE 2018-08-16

Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate patient perception of value within framework a multidisciplinary team approach. The aim this study was develop questionnaire assess preferences HNSCC patients with respect disease trajectory, expected treatment, toxicities. In accordance standardized EORTC Quality Life Group’s methodology development quality life modules, phase 1–2 envisaged. Following systematic review...

10.3390/cancers12123577 article EN Cancers 2020-11-30

6017 Background: Response to IC with triplet regimens adding taxanes cisplatin and 5-fluorouracil (TPF), followed by chemoradiotherapy (CRT) for LASCCHN, is usually evaluated after 2 cycles of IC, based on bidimensional WHO or modified criteria. Concerns regarding toxicity profile TPF suggest a potential benefit an early response evaluation approach that could select patients who would be spared from toxic regimen promptly started alternative treatment. The aim this study assess the ability...

10.1200/jco.2013.31.15_suppl.6017 article EN Journal of Clinical Oncology 2013-05-20

e16540 Background: Metastatic castration-resistant prostate cancer (mCRPC) phenotype involves androgen-receptor signalling mechanisms that support the use of enzalutamide (EZ) and abiraterone (Abi). These therapies improve overall survival (OS) quality-of-life, with a favourable safety profile. There is no validated data defining best drug or sequence to be used. Methods: A retrospective cohort mCRPC patients (pts) was analysed at AC Camargo Cancer Center. The primary objective compare...

10.1200/jco.2019.37.15_suppl.e16540 article EN Journal of Clinical Oncology 2019-05-20

Differentiated thyroid carcinoma (DTC) accounts for most cases of cancer, and the heterogeneity DTC requires that management decisions be taken by a multidisciplinary team involving endocrinologists, head neck surgeons, nuclear medicine physicians, pathologists, radiologists, radiation oncologists, medical oncologists. It is important nonspecialists to recognize refer patients with who will benefit from specialized approach. Recent advances in knowledge changes call need raise awareness on [...]

10.20945/2359-4292-2023-0375 article EN cc-by Archives of Endocrinology and Metabolism 2024-01-01
Coming Soon ...